Literature DB >> 21664093

Low lifetime recreational activity is a risk factor for peripheral arterial disease.

Andrew M Wilson1, Amir H Sadrzadeh-Rafie, Jonathan Myers, Themistocles Assimes, Kevin T Nead, Mamie Higgins, Andre Gabriel, Jeffrey Olin, John P Cooke.   

Abstract

BACKGROUND: The relationship between lifetime physical activity and the risk of developing peripheral arterial disease (PAD) is not known.
METHODS: We studied 1381 patients referred for elective coronary angiography in a point prevalence analysis. PAD was defined as ankle-brachial index (ABI) <0.9 at the time or a history of revascularization of the lower extremities regardless of ABI measure. We used a validated physical activity questionnaire to retrospectively measure each patient's lifetime recreational activity (LRA). Multivariate and logistic regression analyses were used to assess the independent association of LRA to ABI and the presence of PAD.
RESULTS: PAD was present in 19% (n = 258) of all subjects. Subjects reporting no regular LRA had greater diastolic blood pressure and were more likely to be female. They had lower average ABI, and a higher proportion had PAD (25.6%). In a regression model, including traditional risk factors and LRA, multivariate analysis showed that age (P < .001), female gender (P < .001), systolic blood pressure (P = .014), fasting glucose (P < .001), serum triglycerides (P = .02), and cumulative pack years (P < .001) were independent negative predictors of ABI, and LRA was a positive predictor of ABI (P < .001). History of sedentary lifestyle independently increased the odds ratio for PAD (odds ratio, 0.46; 95% confidence interval, 1.01-2.10) when assessed by logistic regression. Intriguingly, there is a correlation between physical activity and gender, such that women with low LRA are at greatest risk.
CONCLUSION: Recalled LRA is positively correlated to ABI and associated with PAD. Whereas the mechanism for this effect is not clear, LRA may be a useful clinical screening tool for PAD risk, and strategies to increase adult recreational activity may reduce the burden of PAD later in life.
Copyright © 2011 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21664093      PMCID: PMC3152670          DOI: 10.1016/j.jvs.2011.02.052

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  39 in total

1.  Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group.

Authors:  A B Newman; L Shemanski; T A Manolio; M Cushman; M Mittelmark; J F Polak; N R Powe; D Siscovick
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

2.  Relationship between free-living daily physical activity and peripheral circulation in patients with intermittent claudication.

Authors:  A W Gardner; L A Killewich; L I Katzel; C J Womack; P S Montgomery; R B Otis; T Fonong
Journal:  Angiology       Date:  1999-04       Impact factor: 3.619

3.  Fitness versus physical activity patterns in predicting mortality in men.

Authors:  Jonathan Myers; Amir Kaykha; Sheela George; Joshua Abella; Naima Zaheer; Scott Lear; Takuya Yamazaki; Victor Froelicher
Journal:  Am J Med       Date:  2004-12-15       Impact factor: 4.965

4.  Absence of age-related increase in central arterial stiffness in physically active women.

Authors:  H Tanaka; C A DeSouza; D R Seals
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-01       Impact factor: 8.311

5.  Energy cost of stair climbing and descending on the college alumnus questionnaire.

Authors:  D R Bassett; J A Vachon; A O Kirkland; E T Howley; G E Duncan; K R Johnson
Journal:  Med Sci Sports Exerc       Date:  1997-09       Impact factor: 5.411

Review 6.  Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists.

Authors:  W R Hiatt; A T Hirsch; J G Regensteiner; E P Brass
Journal:  Circulation       Date:  1995-08-01       Impact factor: 29.690

7.  Compendium of physical activities: classification of energy costs of human physical activities.

Authors:  B E Ainsworth; W L Haskell; A S Leon; D R Jacobs; H J Montoye; J F Sallis; R S Paffenbarger
Journal:  Med Sci Sports Exerc       Date:  1993-01       Impact factor: 5.411

8.  Inflammatory markers, D-dimer, pro-thrombotic factors, and physical activity levels in patients with peripheral arterial disease.

Authors:  Mary Mcgrae McDermott; Philip Greenland; Jack M Guralnik; Luigi Ferrucci; David Green; Kiang Liu; Michael H Criqui; Joseph R Schneider; Cheeling Chan; Paul Ridker; William H Pearce; Gary Martin; Elizabeth Clark; Lloyd Taylor
Journal:  Vasc Med       Date:  2004-05       Impact factor: 3.239

9.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

10.  C-reactive protein genotypes affect baseline, but not exercise training-induced changes, in C-reactive protein levels.

Authors:  Thomas O Obisesan; Christiaan Leeuwenburgh; Tracey Phillips; Robert E Ferrell; Dana A Phares; Steven J Prior; James M Hagberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-07-22       Impact factor: 8.311

View more
  21 in total

1.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

2.  A compendium on peripheral arterial disease.

Authors:  John P Cooke; Zhen Chen
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

Review 3.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

Review 4.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2012-12-12       Impact factor: 29.690

Review 5.  Development of pluripotent stem cells for vascular therapy.

Authors:  Katharina S Volz; Erik Miljan; Amanda Khoo; John P Cooke
Journal:  Vascul Pharmacol       Date:  2012-02-23       Impact factor: 5.773

6.  Usefulness of the addition of beta-2-microglobulin, cystatin C and C-reactive protein to an established risk factors model to improve mortality risk prediction in patients undergoing coronary angiography.

Authors:  Kevin T Nead; Margaret J Zhou; Roxanne Diaz Caceres; Stephen J Sharp; Mackenzie R Wehner; Jeffrey W Olin; John P Cooke; Nicholas J Leeper
Journal:  Am J Cardiol       Date:  2013-01-01       Impact factor: 2.778

7.  The effect of exercise training on ankle-brachial index in type 2 diabetes.

Authors:  Bethany Barone Gibbs; Devon A Dobrosielski; Andrew D Althouse; Kerry J Stewart
Journal:  Atherosclerosis       Date:  2013-07-14       Impact factor: 5.162

8.  The combination of 9p21.3 genotype and biomarker profile improves a peripheral artery disease risk prediction model.

Authors:  Kelly P Downing; Kevin T Nead; Yoko Kojima; Themistocles Assimes; Lars Maegdefessel; Thomas Quertermous; John P Cooke; Nicholas J Leeper
Journal:  Vasc Med       Date:  2013-12-09       Impact factor: 3.239

9.  Exercise capacity is the strongest predictor of mortality in patients with peripheral arterial disease.

Authors:  Nicholas J Leeper; Jonathan Myers; Margaret Zhou; Kevin T Nead; Arshiya Syed; Yoko Kojima; Roxanne Diaz Caceres; John P Cooke
Journal:  J Vasc Surg       Date:  2012-10-06       Impact factor: 4.268

10.  Alternative ankle-brachial index method identifies additional at-risk individuals.

Authors:  Kevin T Nead; John P Cooke; Jeffrey W Olin; Nicholas J Leeper
Journal:  J Am Coll Cardiol       Date:  2013-05-22       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.